United States · 
Who invested in Exai Bio?
Exai Bio's investors include Two Sigma Ventures, Casdin Capital and S32.
United States · Series A startup
Who invested in Exai Bio
Funding summaryUpdated 26 Oct 2026
$68Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $68MDec 2021
- Investors
- 3
The rounds
- Dec 2021
Founders and team
From Exai Bio's own website and the SEC filings it signed: 5 on the team.
- Michael NallPresident & Chief Operating Officer
- Carolyn WangVice President, People and Culture
- Lee SchwartzbergChief Medical Officer
- Hani A. GoodarziChief Technology Officer
- Patrick A. ArensdorfExecutive Officer, Directori
On the board, as filediAlexander A. ParkerMichael A. Pellini
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Exai Bio
How much has Exai Bio raised?
Exai Bio has raised $68M across 1 round since 2021.
When did Exai Bio last raise?
Exai Bio's most recent round was a Series A of $68M in Dec 2021.
What was Exai Bio's biggest round?
Its most recent round, $68M in Dec 2021, is also its largest on record.
Who backed Exai Bio first?
Exai Bio's first round on record, in Dec 2021, was backed by Two Sigma Ventures, Casdin Capital and S32.
What stage is Exai Bio at?
Exai Bio's latest named round is a Series A, in Dec 2021.
Where is Exai Bio based?
Exai Bio is based in the United States.
Companies like Exai Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.